A new study has found another benefit of GLP-1 drugs, including Ozempic and Wegovy. In addition to helping with weight loss, they lower the risk of Alzheimer’s disease and dementia for Type 2 diabetics. Health reporter Katherine Ward has the details.
Health
GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes
More Videos
-
Mental health experts weigh in on how to manage stress during the holiday season
-
Health Matters: Pillsbury brand Pizza Pops recalled due to E. coli concerns
-
Many Canadians skipping travel vaccines, Rexall report suggests
-
Health Matters: New regulations targeting illegal drug chemicals, equipment
-
Trump reclassifies marijuana as less dangerous drug for health and study purposes
-
Health Matters: Eli Lilly says new oral pill helps maintain weight loss
You are viewing an Accelerated Mobile Webpage.
View Original Article